G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development. G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing. " title="" class="btn" data-container="body" data-html="true" data-id="208680" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="G.CLIPS biotech"> 870
Activities
Technologies
Entity types
Location
31670 Labège, France
Labège
France
Employees
Scale: 2-10
Estimated: 8
SIREN
885068460Engaged corporates
12Added in Motherbase
1 year, 6 months agoENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS
G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.
We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.
G.Mixes®
G.Select® Assay
G.Lipidomics®
G.Validation® Assay
We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.
G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.
membrane proteins, drug targets, protein stabilisation, in vitro, and in cellulo
ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS
G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.
We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.
G.Mixes®
G.Select® Assay
G.Lipidomics®
G.Validation® Assay
We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.
G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.
Pathology-like targets for drug & antibody discovery - Quick decision tool for conditions of membrane proteins stabilization in specific conformation & environment
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Toulouse Tech Transfer | Other 18 Jan 2024 | | |
![]() Ville de Toulouse Government Administration, French metropolis | Ville de Toulouse Government Administration, French metropolis | Other 18 Jan 2024 | | |
![]() Aerospace Valley Public business cluster, French Cluster, Aviation and Aerospace Component Manufacturing | Aerospace Valley Public business cluster, French Cluster, Aviation and Aerospace Component Manufacturing | Other 18 Jan 2024 | | |
![]() CEA Research | CEA Research | Other 18 Jan 2024 | | |
![]() Créalia Occitanie Civic and Social Organizations | Créalia Occitanie Civic and Social Organizations | Other 30 Sep 2024 | | |
![]() Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 12 Oct 2023 | | |
![]() Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Other 12 Oct 2023 | | |
![]() Nubbo, Incubateur à mission Business Consulting and Services | Nubbo, Incubateur à mission Business Consulting and Services | Other 10 Oct 2024 | | |
![]() France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 31 May 2023 | | |
![]() Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 29 Oct 2024 | |